First Time Loading...
P

PCC Rokita SA
WSE:PCR

Watchlist Manager
PCC Rokita SA
WSE:PCR
Watchlist
Price: 94.4 PLN -4.65% Market Closed
Updated: May 17, 2024
Section:
 

Relative Value

The Relative Value of one PCR stock under the Base Case scenario is 106.82 PLN. Compared to the current market price of 94.4 PLN, PCC Rokita SA is Undervalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PCR Relative Value
Base Case
106.82 PLN
Undervaluation 12%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
7
vs Industry
67
Median 3Y
0.7
Median 5Y
0.7
Industry
1.5
Forward
0.8
More Details
7
P/E
P/E
Price to Earnings
7
vs History
23
vs Industry
63
Median 3Y
3.8
Median 5Y
5.6
Industry
22.2
Forward
38.3
More Details
3.7
P/OCF
P/OCF
Price to OCF
3.7
vs History
3
vs Industry
68
Median 3Y
3
Median 5Y
2.9
Industry
12.9
More Details
9
P/FCFE
P/FCFE
Price to FCFE
9
vs History
22
vs Industry
46
Median 3Y
6.8
Median 5Y
6.4
Industry
19.2
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
38
vs Industry
55
Median 3Y
1.4
Median 5Y
1.4
Industry
1.7
More Details
0.9
EV/S
EV/S
Enterprise Value to Sales
0.9
vs History
50
vs Industry
65
Median 3Y
0.9
Median 5Y
0.9
Industry
1.6
Forward
0.9
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
39
vs Industry
66
Median 3Y
2.6
Median 5Y
3.6
Industry
7.2
More Details
3.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.9
vs History
47
vs Industry
68
Median 3Y
2.9
Median 5Y
4
Industry
13.8
Forward
7.1
More Details
5.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
5.8
vs History
47
vs Industry
63
Median 3Y
3.9
Median 5Y
6
Industry
17.7
Forward
22.4
More Details
4.1
EV/OCF
EV/OCF
Enterprise Value to OCF
4.1
vs History
39
vs Industry
67
Median 3Y
3.7
Median 5Y
4.1
Industry
13.7
More Details
7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7
vs History
46
vs Industry
43
Median 3Y
5.2
Median 5Y
7.3
Industry
19.2
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
30
vs Industry
55
Median 3Y
1
Median 5Y
1
Industry
1.3
More Details

Multiples Across Competitors

PCR Competitors Multiples
PCC Rokita SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
PCC Rokita SA
WSE:PCR
1.9B PLN 0.8 7 3.9 5.8
US
Sherwin-Williams Co
NYSE:SHW
79.4B USD 3.5 32.9 20.9 24.5
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.7T JPY 4.8 22.4 10.7 14.2
US
Ecolab Inc
NYSE:ECL
66.5B USD 4.3 43 22.8 32
CH
Sika AG
SIX:SIKA
45.1B CHF 4 42.4 23 29.9
CH
Givaudan SA
SIX:GIVN
38.5B CHF 5.6 43.1 28.7 37.8
CN
Wanhua Chemical Group Co Ltd
SSE:600309
282.8B CNY 1.6 16.7 17.6 17.6
US
Dupont De Nemours Inc
NYSE:DD
33.1B USD 2.8 93.5 13.7 23.2
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.7T INR 7.6 49.3 35 39.5
US
PPG Industries Inc
NYSE:PPG
31.5B USD 1.7 22.4 12.8 16
CH
DSM-Firmenich AG
AEX:DSFIR
28.8B EUR 2.7 13.5 34.1 -66.7

See Also

Summary
PCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
PCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PCR stock valuation using valuation multiples.
Wall Street Estimates
PCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.